Surrogate endpoint

Triglyceride

Biochemistry

Disease

Biology

Endocrinology

Index (typography)

Insulin

Angiology

Insulin resistance

Computer science

World Wide Web

Cholesterol

Internal medicine

Diabetes mellitus

Biomarker

Medicine

Cardiovascular Diabetology

The triglyceride-glucose (TyG) index has been identified as a reliable alternative biomarker of insulin resistance (IR). Recently, a considerable number of studies have provided robust statistical evidence suggesting that the TyG index is associated with the development and prognosis of cardiovascular disease (CVD). Nevertheless, the application of the TyG index as a marker of CVD has not systemically been evaluated, and even less information exists regarding the underlying mechanisms associated with CVD. To this end, in this review, we summarize the history of the use of the TyG index as a surrogate marker for IR. We aimed to highlight the application value of the TyG index for a variety of CVD types and to explore the potential limitations of using this index as a predictor for cardiovascular events to improve its application value for CVD and provide more extensive and precise supporting evidence.

Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations